Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Oct;92(4):1974–1980. doi: 10.1172/JCI116791

Glucocorticoid deficiency increases phospholipase A2 activity in rats.

B S Vishwanath 1, F J Frey 1, M J Bradbury 1, M F Dallman 1, B M Frey 1
PMCID: PMC288364  PMID: 8408650

Abstract

An important mechanism for the antiinflammatory effect of pharmacological doses of glucocorticoids is the inhibition of arachidonic acid release from phospholipids by phospholipase A2 (PLA2). As a corollary, one might predict that low endogenous concentrations of glucocorticoids favor inflammatory disease states. Indeed, clinical and experimental observations revealed an association between glucocorticoid deficiency and disease states caused by immunological and/or inflammatory mechanisms. The purpose of the present investigation was to study the regulation of PLA2 mRNA, protein, and enzyme activity in adrenalectomized (ADX) rats where glucocorticoid concentrations were below physiological levels. The mRNA of group I and II PLA2 were measured by PCR. Group II PLA2 mRNA was increased by 126 +/- 9% in lung tissue of ADX rats, whereas group I PLA2 was increased only by 27 +/- 1.5%. The increase in group II mRNA in ADX rats was reflected by a corresponding increase of group II PLA2 protein (70-100%) in lung, spleen, liver, and kidney. This increase was reversed by the administration of exogenous corticosterone. After ADX, the percentage increase in total PLA2 activity was higher than that of mRNA or PLA2 protein, suggesting that the activity of the enzyme was modulated by inhibitors or activators. The concentration of lipocortin-I, an inhibitor of PLA2 enzyme was strongly correlated with the activity of PLA2 in the tissues (lung, spleen, liver, and kidney). In all these tissues, the concentrations of lipocortin-I declined after ADX. Thus upregulation of PLA2 enzyme and downregulation of lipocortin-I might account for the enhanced inflammatory response in hypoglucocorticoid states.

Full text

PDF
1974

Images in this article

1976Image
on p.1976
1976Image
on p.1976
1977Image
on p.1977
1977Image
on p.1977
1977Image
on p.1977

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrose M. P., Bahns C. L., Hunninghake G. W. Lipocortin I production by human alveolar macrophages. Am J Respir Cell Mol Biol. 1992 Jan;6(1):17–21. doi: 10.1165/ajrcmb/6.1.17. [DOI] [PubMed] [Google Scholar]
  2. Bertini R., Bianchi M., Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med. 1988 May 1;167(5):1708–1712. doi: 10.1084/jem.167.5.1708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beutler B., Krochin N., Milsark I. W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 1986 May 23;232(4753):977–980. doi: 10.1126/science.3754653. [DOI] [PubMed] [Google Scholar]
  4. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  5. Bonventre J. V., Nemenoff R. Renal tubular arachidonic acid metabolism. Kidney Int. 1991 Mar;39(3):438–449. doi: 10.1038/ki.1991.55. [DOI] [PubMed] [Google Scholar]
  6. Browning J. L., Ward M. P., Wallner B. P., Pepinsky R. B. Studies on the structural properties of lipocortin-1 and the regulation of its synthesis by steroids. Prog Clin Biol Res. 1990;349:27–45. [PubMed] [Google Scholar]
  7. CARRYER H. M., SHERRICK D. W., GASTINEAU C. F. Occurrence of allergic disease in patients with adrenal cortical hypofunction. J Am Med Assoc. 1960 Mar 26;172:1356–1360. doi: 10.1001/jama.1960.03020130014005. [DOI] [PubMed] [Google Scholar]
  8. Camussi G., Tetta C., Turello E., Baglioni C. Anti-inflammatory peptides inhibit synthesis of platelet-activating factor. Prog Clin Biol Res. 1990;349:69–80. [PubMed] [Google Scholar]
  9. Cirino G., Peers S. H., Flower R. J., Browning J. L., Pepinsky R. B. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci U S A. 1989 May;86(9):3428–3432. doi: 10.1073/pnas.86.9.3428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Clark J. D., Lin L. L., Kriz R. W., Ramesha C. S., Sultzman L. A., Lin A. Y., Milona N., Knopf J. L. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 1991 Jun 14;65(6):1043–1051. doi: 10.1016/0092-8674(91)90556-e. [DOI] [PubMed] [Google Scholar]
  11. Davidson F. F., Dennis E. A., Powell M., Glenney J. R., Jr Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J Biol Chem. 1987 Feb 5;262(4):1698–1705. [PubMed] [Google Scholar]
  12. Fava R. A., McKanna J., Cohen S. Lipocortin I (p35) is abundant in a restricted number of differentiated cell types in adult organs. J Cell Physiol. 1989 Nov;141(2):284–293. doi: 10.1002/jcp.1041410209. [DOI] [PubMed] [Google Scholar]
  13. Flower R. J., Blackwell G. J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 1979 Mar 29;278(5703):456–459. doi: 10.1038/278456a0. [DOI] [PubMed] [Google Scholar]
  14. Flower R. J., Parente L., Persico P., Salmon J. A. A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. Br J Pharmacol. 1986 Jan;87(1):57–62. doi: 10.1111/j.1476-5381.1986.tb10156.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Frey B. M., Frey F. J., Lingappa V. R., Trachsel H. Expression of human recombinant lipocortin I in a wheat-germ cell-free system and Xenopus oocytes. Lipocortin is not secreted. Biochem J. 1991 Apr 1;275(Pt 1):219–225. doi: 10.1042/bj2750219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Frey F. J. Kinetics and dynamics of prednisolone. Endocr Rev. 1987 Nov;8(4):453–473. doi: 10.1210/edrv-8-4-453. [DOI] [PubMed] [Google Scholar]
  17. Frey F. J., Trost B., Zimmermann A. Autoimmune adrenalitis, asthma and membranoproliferative glomerulonephritis. Am J Nephrol. 1991;11(4):341–342. doi: 10.1159/000168334. [DOI] [PubMed] [Google Scholar]
  18. Gebicke-Haerter P. J., Schobert A., Dieter P., Honegger P., Hertting G. Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. J Neurochem. 1991 Jul;57(1):175–183. doi: 10.1111/j.1471-4159.1991.tb02113.x. [DOI] [PubMed] [Google Scholar]
  19. Ghiara P., Meli R., Parente L., Persico P. Distinct inhibition of membrane-bound and lysosomal phospholipase A2 by glucocorticoid-induced proteins. Biochem Pharmacol. 1984 May 1;33(9):1445–1450. doi: 10.1016/0006-2952(84)90411-8. [DOI] [PubMed] [Google Scholar]
  20. Goulding N. J., Godolphin J. L., Sharland P. R., Peers S. H., Sampson M., Maddison P. J., Flower R. J. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet. 1990 Jun 16;335(8703):1416–1418. doi: 10.1016/0140-6736(90)91445-g. [DOI] [PubMed] [Google Scholar]
  21. Goulding N. J., Guyre P. M. Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol. 1993 Feb;5(1):108–113. doi: 10.1016/0952-7915(93)90089-b. [DOI] [PubMed] [Google Scholar]
  22. Green M., Lim K. H. Bronchial asthma with Addison's disease. Lancet. 1971 Jun 5;1(7710):1159–1162. doi: 10.1016/s0140-6736(71)91664-3. [DOI] [PubMed] [Google Scholar]
  23. Gronich J. H., Bonventre J. V., Nemenoff R. A. Purification of a high-molecular-mass form of phospholipase A2 from rat kidney activated at physiological calcium concentrations. Biochem J. 1990 Oct 1;271(1):37–43. doi: 10.1042/bj2710037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Haigler H. T., Schlaepfer D. D., Burgess W. H. Characterization of lipocortin I and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors. J Biol Chem. 1987 May 15;262(14):6921–6930. [PubMed] [Google Scholar]
  25. Hazen S. L., Ford D. A., Gross R. W. Activation of a membrane-associated phospholipase A2 during rabbit myocardial ischemia which is highly selective for plasmalogen substrate. J Biol Chem. 1991 Mar 25;266(9):5629–5633. [PubMed] [Google Scholar]
  26. Hazen S. L., Gross R. W. Identification and characterization of human myocardial phospholipase A2 from transplant recipients suffering from end-stage ischemic heart disease. Circ Res. 1992 Mar;70(3):486–495. doi: 10.1161/01.res.70.3.486. [DOI] [PubMed] [Google Scholar]
  27. Heinrikson R. L., Krueger E. T., Keim P. S. Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants. J Biol Chem. 1977 Jul 25;252(14):4913–4921. [PubMed] [Google Scholar]
  28. Hirata F., Matsuda K., Notsu Y., Hattori T., del Carmine R. Phosphorylation at a tyrosine residue of lipomodulin in mitogen-stimulated murine thymocytes. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4717–4721. doi: 10.1073/pnas.81.15.4717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hirata F. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem. 1981 Aug 10;256(15):7730–7733. [PubMed] [Google Scholar]
  30. Ishizaki J., Ohara O., Nakamura E., Tamaki M., Ono T., Kanda A., Yoshida N., Teraoka H., Tojo H., Okamoto M. cDNA cloning and sequence determination of rat membrane-associated phospholipase A2. Biochem Biophys Res Commun. 1989 Aug 15;162(3):1030–1036. doi: 10.1016/0006-291x(89)90777-8. [DOI] [PubMed] [Google Scholar]
  31. Knudsen P. J., Dinarello C. A., Strom T. B. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol. 1987 Dec 15;139(12):4129–4134. [PubMed] [Google Scholar]
  32. Kobayashi M., Bansal V. S., Singh I., Kanfer J. N. Dexamethasone-induced reduction of phospholipase D activity in the rat. Possible role of lipocortin. FEBS Lett. 1988 Aug 29;236(2):380–382. doi: 10.1016/0014-5793(88)80060-7. [DOI] [PubMed] [Google Scholar]
  33. Kramer R. M., Hession C., Johansen B., Hayes G., McGray P., Chow E. P., Tizard R., Pepinsky R. B. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem. 1989 Apr 5;264(10):5768–5775. [PubMed] [Google Scholar]
  34. Laue L., Kawai S., Brandon D. D., Brightwell D., Barnes K., Knazek R. A., Loriaux D. L., Chrousos G. P. Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. J Steroid Biochem. 1988 Jun;29(6):591–598. doi: 10.1016/0022-4731(88)90156-2. [DOI] [PubMed] [Google Scholar]
  35. Machoczek K., Fischer M., Söling H. D. Lipocortin I and lipocortin II inhibit phosphoinositide- and polyphosphoinositide-specific phospholipase C. The effect results from interaction with the substrates. FEBS Lett. 1989 Jul 17;251(1-2):207–212. doi: 10.1016/0014-5793(89)81456-5. [DOI] [PubMed] [Google Scholar]
  36. Mugridge K. G., Perretti M., Becherucci C., Parente L. Persistent effects of interleukin-1 on smooth muscle preparations from adrenalectomized rats: implications for increased phospholipase-A2 activity via stimulation of 5-lipoxygenase. J Pharmacol Exp Ther. 1991 Jan;256(1):29–37. [PubMed] [Google Scholar]
  37. Munck A., Guyre P. M., Holbrook N. J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984 Winter;5(1):25–44. doi: 10.1210/edrv-5-1-25. [DOI] [PubMed] [Google Scholar]
  38. Murakami M., Kudo I., Nakamura H., Yokoyama Y., Mori H., Inoue K. Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14-kDa group II phospholipase A2. FEBS Lett. 1990 Jul 30;268(1):113–116. doi: 10.1016/0014-5793(90)80986-s. [DOI] [PubMed] [Google Scholar]
  39. Märki F., Franson R. Endogenous suppression of neutral-active and calcium-dependent phospholipase A2 in human polymorphonuclear leukocytes. Biochim Biophys Acta. 1986 Nov 14;879(2):149–156. doi: 10.1016/0005-2760(86)90097-4. [DOI] [PubMed] [Google Scholar]
  40. Nakano T., Arita H. Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid. FEBS Lett. 1990 Oct 29;273(1-2):23–26. doi: 10.1016/0014-5793(90)81042-m. [DOI] [PubMed] [Google Scholar]
  41. Nakano T., Ohara O., Teraoka H., Arita H. Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem. 1990 Jul 25;265(21):12745–12748. [PubMed] [Google Scholar]
  42. Nakano T., Ohara O., Teraoka H., Arita H. Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett. 1990 Feb 12;261(1):171–174. doi: 10.1016/0014-5793(90)80663-4. [DOI] [PubMed] [Google Scholar]
  43. Ohara O., Tamaki M., Nakamura E., Tsuruta Y., Fujii Y., Shin M., Teraoka H., Okamoto M. Dog and rat pancreatic phospholipases A2: complete amino acid sequences deduced from complementary DNAs. J Biochem. 1986 Mar;99(3):733–739. doi: 10.1093/oxfordjournals.jbchem.a135532. [DOI] [PubMed] [Google Scholar]
  44. Oka S., Arita H. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J Biol Chem. 1991 May 25;266(15):9956–9960. [PubMed] [Google Scholar]
  45. Pepinsky R. B., Sinclair L. K., Browning J. L., Mattaliano R. J., Smart J. E., Chow E. P., Falbel T., Ribolini A., Garwin J. L., Wallner B. P. Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates. J Biol Chem. 1986 Mar 25;261(9):4239–4246. [PubMed] [Google Scholar]
  46. Pierik A. J., Nijssen J. G., Aarsman A. J., Van den Bosch H. Calcium-independent phospholipase A2 in rat tissue cytosols. Biochim Biophys Acta. 1988 Oct 14;962(3):345–353. doi: 10.1016/0005-2760(88)90264-0. [DOI] [PubMed] [Google Scholar]
  47. Piltch A., Sun L., Fava R. A., Hayashi J. Lipocortin-independent effect of dexamethasone on phospholipase activity in a thymic epithelial cell line. Biochem J. 1989 Jul 15;261(2):395–400. doi: 10.1042/bj2610395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Relton J. K., Strijbos P. J., O'Shaughnessy C. T., Carey F., Forder R. A., Tilders F. J., Rothwell N. J. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J Exp Med. 1991 Aug 1;174(2):305–310. doi: 10.1084/jem.174.2.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Rothhut B., Russo-Marie F., Wood J., DiRosa M., Flower R. J. Further characterization of the glucocorticoid-induced antiphospholipase protein "renocortin". Biochem Biophys Res Commun. 1983 Dec 28;117(3):878–884. doi: 10.1016/0006-291x(83)91678-9. [DOI] [PubMed] [Google Scholar]
  50. Sautebin L., Carnuccio R., Ialenti A., Di Rosa M. Lipocortin and vasocortin: two species of anti-inflammatory proteins mimicking the effects of glucocorticoids. Pharmacol Res. 1992 Jan;25(1):1–12. doi: 10.1016/s1043-6618(05)80058-1. [DOI] [PubMed] [Google Scholar]
  51. Seilhamer J. J., Pruzanski W., Vadas P., Plant S., Miller J. A., Kloss J., Johnson L. K. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J Biol Chem. 1989 Apr 5;264(10):5335–5338. [PubMed] [Google Scholar]
  52. Solito E., Raugei G., Melli M., Parente L. Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FEBS Lett. 1991 Oct 21;291(2):238–244. doi: 10.1016/0014-5793(91)81293-h. [DOI] [PubMed] [Google Scholar]
  53. Sternberg E. M., Hill J. M., Chrousos G. P., Kamilaris T., Listwak S. J., Gold P. W., Wilder R. L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2374–2378. doi: 10.1073/pnas.86.7.2374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Vishwanath B. S., Fawzy A. A., Franson R. C. Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid. Inflammation. 1988 Dec;12(6):549–561. doi: 10.1007/BF00914317. [DOI] [PubMed] [Google Scholar]
  55. Vishwanath B. S., Frey F. J., Bradbury M., Dallman M. F., Frey B. M. Adrenalectomy decreases lipocortin-I messenger ribonucleic acid and tissue protein content in rats. Endocrinology. 1992 Feb;130(2):585–591. doi: 10.1210/endo.130.2.1531128. [DOI] [PubMed] [Google Scholar]
  56. Wallner B. P., Mattaliano R. J., Hession C., Cate R. L., Tizard R., Sinclair L. K., Foeller C., Chow E. P., Browing J. L., Ramachandran K. L. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature. 1986 Mar 6;320(6057):77–81. doi: 10.1038/320077a0. [DOI] [PubMed] [Google Scholar]
  57. Wang A. M., Doyle M. V., Mark D. F. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9717–9721. doi: 10.1073/pnas.86.24.9717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Wong W. T., Frost S. C., Nick H. S. Protein-synthesis-dependent induction of annexin I by glucocorticoid. Biochem J. 1991 Apr 15;275(Pt 2):313–319. doi: 10.1042/bj2750313. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES